Genetic Testing in Adult Neurology Patients with Catherine Schultz, MS, CGC

Clinical genetic testing for neurological conditions has long been used in the pediatric population to identify genetic etiologies and inform medical management decisions; however, the utility in adult populations has not been well-explored. Previous studies regarding test utilization and diagnostic yield in a general adult neurological population are scarce and limited to a small cohort in one clinic. The purpose of this webinar is to review the findings of a recent research study analyzing the characteristics and detection rates of adult patients with neurological phenotypes undergoing genetic testing at a commercial laboratory.

Catherine Schultz, MS, CGC | Presenter

Genomic Science Liaison, Ambry Genetics

Catherine Schultz is a certified genetic counselor and Specialty Genomic Science Liaison at Ambry Genetics. She completed her BS in Biology at the College of Charleston and received her MS in Genetic Counseling from the University of Alabama at Birmingham. After graduate school, Catherine worked for several years as a multidisciplinary genetic counselor at University of Alabama at Birmingham in Birmingham, AL. In 2016 she moved to Oklahoma City and transitioned to her current role at Ambry Genetics. As a Genomic Science Liaison for the Southcentral United States, she serves as a clinical liaison for the field team to educate health care providers and other key opinion leaders on genetic testing and genomic medicine.

Meghan Towne, MS, CGC, LCGC | Moderator

Sr. Clinical Research Specialist, Ambry Genetics

After obtaining her B.S. in biology with a minor in chemistry from Boston College in 2007, Meghan attended Boston University School of Medicine for her graduate studies in Genetic Counseling. Her studies piqued her interest in the impact of innovative technologies on diagnosing and connecting families with rare genetic disorders. Meghan worked for seven years at Boston Children’s Hospital developing the institutional infrastructure for gene discovery, enhancing research collaborations, and evaluating the utility of genomic sequencing in newborns. In 2016, Meghan joined Ambry as a reporting genetic counselor on the clinical genomics team. She maintains her research connections to the Boston community by serving as a voting member of the Massachusetts General Hospital IRB and as a course coordinator for research seminar series at Boston University.